Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients

Giuseppe Boriani1, Niccolo' Bonini2, Marco Vitolo2

  • 1Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Via del Pozzo, 71, Modena 41124, Italy.

PubMed

Insights

Asymptomatic atrial fibrillation (AF) poses a higher risk for adverse outcomes, specifically in patients with heart failure (HF) and reduced left ventricular ejection fraction (LVEF). This highlights the importance of considering AF symptom status in HF management.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Epidemiology

Background:

  • Atrial fibrillation (AF) management requires understanding outcomes in diverse patient subgroups.
  • The prognostic implications of asymptomatic versus symptomatic AF in patients with heart failure (HF) and varying left ventricular ejection fraction (LVEF) remain unclear.

Purpose of the Study:

  • To clarify the outcome differences between asymptomatic and symptomatic AF patients stratified by HF and LVEF status.
  • To investigate the independent association of asymptomatic AF with adverse events in specific HF and LVEF subgroups.

Main Methods:

  • Prospective observational study including 8096 AF patients.
  • Patients categorized into 8 groups based on overt HF presence and LVEF (≤40% or >40%).
  • Follow-up for composite outcomes (all-cause death, MACE) and analysis of asymptomatic vs. symptomatic AF impact.

Main Results:

  • No significant difference in the composite outcome between asymptomatic and symptomatic AF across the entire cohort.
  • Asymptomatic AF patients with HF and LVEF ≤40% showed significantly worse outcomes (composite outcome and all-cause death) compared to symptomatic AF patients in the same group.
  • Adjusted analysis revealed asymptomatic AF with HF and LVEF ≤40% as an independent predictor of higher risk for composite outcomes and all-cause death.

Conclusions:

  • In a large European AF cohort, asymptomatic AF did not increase overall 2-year composite outcome risk compared to symptomatic AF.
  • However, asymptomatic AF is associated with adverse outcomes in patients with heart failure and reduced left ventricular ejection fraction (LVEF ≤40%).
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
12
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
22